Early Feeding for Diabetic Ketoacidosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates whether starting an early diet can help treat diabetic ketoacidosis (DKA), a serious condition that causes high blood sugar and acid buildup in the blood. Typically, patients with DKA in intensive care do not receive food immediately. This study aims to determine if eating sooner could be beneficial. It includes two groups: one will begin with a controlled diet starting with liquids (early feeding with an oral diet), and the other will not eat until after their initial treatment. People with DKA in the intensive care unit who can eat and provide consent might be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity to explore new treatment possibilities for DKA.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that early feeding with an oral diet is safe for patients with diabetic ketoacidosis?
Research has shown that starting solid food early for patients with diabetic ketoacidosis (DKA) is generally safe. Several studies indicate that feeding patients within the first 24 hours does not cause additional issues and often results in a shorter hospital stay. One study found that early eating did not increase DKA complications and might even aid faster recovery. Overall, the evidence suggests that early feeding could be a safe option for patients with DKA.12345
Why are researchers excited about this trial?
Researchers are excited about the early feeding approach for diabetic ketoacidosis (DKA) because it challenges the traditional method of keeping patients without oral intake (NPO) until stabilized. Typically, DKA patients are managed with insulin drips and fluid replacement, delaying any oral intake. The innovative aspect of this trial is the introduction of an oral diet sooner, which could potentially enhance recovery by providing necessary nutrients earlier. This approach may help stabilize blood sugar levels and improve patient comfort, offering a more holistic and patient-friendly treatment option.
What evidence suggests that early feeding is effective for diabetic ketoacidosis?
This trial will compare early feeding with withholding oral intake for patients with diabetic ketoacidosis (DKA). Research has shown that early eating is safe for DKA patients. Studies have found that those who begin eating within the first 24 hours may spend less time in intensive care and the hospital. Early eating can help patients recover faster from DKA. Importantly, these studies found no increase in risk or negative effects from early eating. Overall, early eating appears to be a promising way to improve recovery times for DKA patients.14678
Who Is on the Research Team?
Kenneth Kenneth, MD
Principal Investigator
Texas Tech University Health Science Center
Are You a Good Fit for This Trial?
This trial is for men and women aged 18-89 who are in the Medical Intensive Care Unit, can give informed consent, and have diabetic ketoacidosis (high blood sugar over 250 mg/dL, low arterial pH below 7.3, low serum bicarbonate under 15 mEq/L, with ketones in blood or urine).Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either early feeding or nothing per mouth during the treatment of diabetic ketoacidosis
Follow-up
Participants are monitored for safety and effectiveness after treatment, including resolution of DKA and mortality within 30 days
What Are the Treatments Tested in This Trial?
Interventions
- Early feeding with an oral diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas Tech University Health Sciences Center
Lead Sponsor